0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Acute Migraine Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028
Published Date: September 2022
|
Report Code: QYRE-Auto-28H8818
Home | Market Reports | Health| Health Conditions| Pain Management
Global Acute Migraine Drugs Market Outlook 2022
BUY CHAPTERS

Acute Migraine Drugs Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Code: QYRE-Auto-28H8818
Report
September 2022
Pages:107
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Acute Migraine Drugs Market Outlook - 2028

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Acute Migraine Drugs market is projected to reach US$ 3466 million by 2028 from an estimated US$ 2271.1 million in 2022, at a CAGR of 7.3% during 2023 and 2028.

AcuteMigraineDrugsMarket

A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with attacks. Attacks are characterized by moderate–severe, often unilateral, pulsating headache attacks, typically lasting 4 to 72 hours.

Acute Migraine Drugs Market Insights

The top 3 manufacturers held about 29.5% of the market share in 2019, while top 5 hold 41.93%.

This report aims to provide a comprehensive presentation of the global market for Acute Migraine Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Acute Migraine Drugs.

By Company

  • GSK
  • Teva
  • Pfizer
  • Novartis
  • Sun Pharma
  • Grunenthal
  • Endo Pharmaceuticals
  • Merck
  • J & J

Segment by Type

  • Triptans
  • NSAIDs
  • Others

Segment by Application

  • Hospital Pharmacies
  • Drug Stores

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Australia
  • Rest of Asia-Pacific
  • Latin America
  • Mexico
  • Brazil
  • Argentina
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa
1 Study Coverage
1.1 Acute Migraine Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Acute Migraine Drugs Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Market by Application
1.3.1 Global Acute Migraine Drugs Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Acute Migraine Drugs Market Size Estimates and Forecasts
2.1.1 Global Acute Migraine Drugs Revenue 2017-2028
2.1.2 Global Acute Migraine Drugs Sales 2017-2028
2.2 Acute Migraine Drugs Market Size by Region: 2022 Versus 2028
2.3 Acute Migraine Drugs Sales by Region (2017-2028)
2.3.1 Global Acute Migraine Drugs Sales by Region: 2017-2022
2.3.2 Global Acute Migraine Drugs Sales Forecast by Region (2023-2028)
2.3.3 Global Acute Migraine Drugs Sales Market Share by Region (2017-2028)
2.4 Acute Migraine Drugs Market Estimates and Projections by Region (2023-2028)
2.4.1 Global Acute Migraine Drugs Revenue by Region: 2017-2022
2.4.2 Global Acute Migraine Drugs Revenue Forecast by Region (2023-2028)
2.4.3 Global Acute Migraine Drugs Revenue Market Share by Region (2017-2028)
3 Global Acute Migraine Drugs by Manufacturers
3.1 Global Top Acute Migraine Drugs Manufacturers by Sales
3.1.1 Global Acute Migraine Drugs Sales by Manufacturer (2017-2022)
3.1.2 Global Acute Migraine Drugs Sales Market Share by Manufacturer (2017-2022)
3.2 Global Top Acute Migraine Drugs Manufacturers by Revenue
3.2.1 Global Acute Migraine Drugs Revenue by Manufacturer (2017-2022)
3.2.2 Global Acute Migraine Drugs Revenue Share by Manufacturer (2017-2022)
3.3 Global Acute Migraine Drugs Price by Manufacturer (2017-2022)
3.4 Competitive Landscape
3.4.1 Key Acute Migraine Drugs Manufacturers Covered: Ranking by Revenue
3.4.2 Global Acute Migraine Drugs Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.4.3 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Acute Migraine Drugs Manufacturing Base Distribution, Product Type
3.5.1 Acute Migraine Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Acute Migraine Drugs Product Type
3.5.3 Date of International Manufacturers Enter into Acute Migraine Drugs Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 GSK
4.1.1 GSK Corporation Information
4.1.2 GSK Description, Business Overview
4.1.3 GSK Acute Migraine Drugs Products Offered
4.1.4 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.1.5 GSK Acute Migraine Drugs Sales by Product in 2021
4.1.6 GSK Acute Migraine Drugs Sales by Application in 2021
4.1.7 GSK Acute Migraine Drugs Sales by Geographic Area in 2021
4.1.8 GSK Recent Developments
4.2 Teva
4.2.1 Teva Corporation Information
4.2.2 Teva Description, Business Overview
4.2.3 Teva Acute Migraine Drugs Products Offered
4.2.4 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.2.5 Teva Acute Migraine Drugs Sales by Product in 2021
4.2.6 Teva Acute Migraine Drugs Sales by Application in 2021
4.2.7 Teva Acute Migraine Drugs Sales by Geographic Area in 2021
4.2.8 Teva Recent Developments
4.3 Pfizer
4.3.1 Pfizer Corporation Information
4.3.2 Pfizer Description, Business Overview
4.3.3 Pfizer Acute Migraine Drugs Products Offered
4.3.4 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.3.5 Pfizer Acute Migraine Drugs Sales by Product in 2021
4.3.6 Pfizer Acute Migraine Drugs Sales by Application in 2021
4.3.7 Pfizer Acute Migraine Drugs Sales by Geographic Area in 2021
4.3.8 Pfizer Recent Developments
4.4 Novartis
4.4.1 Novartis Corporation Information
4.4.2 Novartis Description, Business Overview
4.4.3 Novartis Acute Migraine Drugs Products Offered
4.4.4 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.4.5 Novartis Acute Migraine Drugs Sales by Product in 2021
4.4.6 Novartis Acute Migraine Drugs Sales by Application in 2021
4.4.7 Novartis Acute Migraine Drugs Sales by Geographic Area in 2021
4.4.8 Novartis Recent Developments
4.5 Sun Pharma
4.5.1 Sun Pharma Corporation Information
4.5.2 Sun Pharma Description, Business Overview
4.5.3 Sun Pharma Acute Migraine Drugs Products Offered
4.5.4 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.5.5 Sun Pharma Acute Migraine Drugs Sales by Product in 2021
4.5.6 Sun Pharma Acute Migraine Drugs Sales by Application in 2021
4.5.7 Sun Pharma Acute Migraine Drugs Sales by Geographic Area in 2021
4.5.8 Sun Pharma Recent Developments
4.6 Grunenthal
4.6.1 Grunenthal Corporation Information
4.6.2 Grunenthal Description, Business Overview
4.6.3 Grunenthal Acute Migraine Drugs Products Offered
4.6.4 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.6.5 Grunenthal Acute Migraine Drugs Sales by Product in 2021
4.6.6 Grunenthal Acute Migraine Drugs Sales by Application in 2021
4.6.7 Grunenthal Acute Migraine Drugs Sales by Geographic Area in 2021
4.6.8 Grunenthal Recent Development
4.7 Endo Pharmaceuticals
4.7.1 Endo Pharmaceuticals Corporation Information
4.7.2 Endo Pharmaceuticals Description, Business Overview
4.7.3 Endo Pharmaceuticals Acute Migraine Drugs Products Offered
4.7.4 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.7.5 Endo Pharmaceuticals Acute Migraine Drugs Sales by Product in 2021
4.7.6 Endo Pharmaceuticals Acute Migraine Drugs Sales by Application in 2021
4.7.7 Endo Pharmaceuticals Acute Migraine Drugs Sales by Geographic Area in 2021
4.7.8 Endo Pharmaceuticals Recent Development
4.8 Merck
4.8.1 Merck Corporation Information
4.8.2 Merck Description, Business Overview
4.8.3 Merck Acute Migraine Drugs Products Offered
4.8.4 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.8.5 Merck Acute Migraine Drugs Sales by Product in 2021
4.8.6 Merck Acute Migraine Drugs Sales by Application in 2021
4.8.7 Merck Acute Migraine Drugs Sales by Geographic Area in 2021
4.8.8 Merck Recent Development
4.9 J & J
4.9.1 J & J Corporation Information
4.9.2 J & J Description, Business Overview
4.9.3 J & J Acute Migraine Drugs Products Offered
4.9.4 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2017-2022)
4.9.5 J & J Acute Migraine Drugs Sales by Product in 2021
4.9.6 J & J Acute Migraine Drugs Sales by Application in 2021
4.9.7 J & J Acute Migraine Drugs Sales by Geographic Area in 2021
4.9.8 J & J Recent Development
5 Breakdown Data by Type
5.1 Global Acute Migraine Drugs Sales by Type (2017-2028)
5.1.1 Global Acute Migraine Drugs Sales by Type (2017-2022)
5.1.2 Global Acute Migraine Drugs Sales Forecast by Type (2023-2028)
5.1.3 Global Acute Migraine Drugs Sales Market Share by Type (2017-2028)
5.2 Global Acute Migraine Drugs Revenue Forecast by Type (2017-2028)
5.2.1 Global Acute Migraine Drugs Revenue by Type (2017-2022)
5.2.2 Global Acute Migraine Drugs Revenue Forecast by Type (2023-2028)
5.2.3 Global Acute Migraine Drugs Revenue Market Share by Type (2017-2028)
5.3 Acute Migraine Drugs Average Selling Price (ASP) by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Acute Migraine Drugs Sales by Application (2017-2028)
6.1.1 Global Acute Migraine Drugs Sales by Application (2017-2022)
6.1.2 Global Acute Migraine Drugs Sales Forecast by Application (2023-2028)
6.1.3 Global Acute Migraine Drugs Sales Market Share by Application (2017-2028)
6.2 Global Acute Migraine Drugs Revenue Forecast by Application (2017-2028)
6.2.1 Global Acute Migraine Drugs Revenue by Application (2017-2022)
6.2.2 Global Acute Migraine Drugs Revenue Forecast by Application (2023-2028)
6.2.3 Global Acute Migraine Drugs Revenue Market Share by Application (2017-2028)
6.3 Acute Migraine Drugs Average Selling Price (ASP) by Application (2017-2028)
7 North America
7.1 North America Acute Migraine Drugs Market Size YoY Growth 2017-2028
7.2 North America Acute Migraine Drugs Market Facts & Figures by Country
7.2.1 North America Acute Migraine Drugs Sales by Country (2017-2028)
7.2.2 North America Acute Migraine Drugs Revenue by Country (2017-2028)
7.3 North America Acute Migraine Drugs Sales by Type
7.4 North America Acute Migraine Drugs Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Acute Migraine Drugs Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Acute Migraine Drugs Market Facts & Figures by Region
8.2.1 Asia-Pacific Acute Migraine Drugs Sales by Region (2017-2028)
8.2.2 Asia-Pacific Acute Migraine Drugs Revenue by Region (2017-2028)
8.3 Asia-Pacific Acute Migraine Drugs Sales by Type
8.4 Asia-Pacific Acute Migraine Drugs Sales by Application
9 Europe
9.1 Europe Acute Migraine Drugs Market Size YoY Growth 2017-2028
9.2 Europe Acute Migraine Drugs Market Facts & Figures by Country
9.2.1 Europe Acute Migraine Drugs Sales by Country (2017-2028)
9.2.2 Europe Acute Migraine Drugs Revenue by Country (2017-2028)
9.3 Europe Acute Migraine Drugs Sales by Type
9.4 Europe Acute Migraine Drugs Sales by Application
10 Latin America
10.1 Latin America Acute Migraine Drugs Market Size YoY Growth 2017-2028
10.2 Latin America Acute Migraine Drugs Market Facts & Figures by Country
10.2.1 Latin America Acute Migraine Drugs Sales by Country (2017-2028)
10.2.2 Latin America Acute Migraine Drugs Revenue by Country (2017-2028)
10.3 Latin America Acute Migraine Drugs Sales by Type
10.4 Latin America Acute Migraine Drugs Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Acute Migraine Drugs Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Acute Migraine Drugs Market Facts & Figures by Country
11.2.1 Middle East and Africa Acute Migraine Drugs Sales by Country (2017-2028)
11.2.2 Middle East and Africa Acute Migraine Drugs Revenue by Country (2017-2028)
11.3 Middle East and Africa Acute Migraine Drugs Sales by Type
11.4 Middle East and Africa Acute Migraine Drugs Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Acute Migraine Drugs Supply Chain Analysis
12.2 Acute Migraine Drugs Key Raw Materials and Upstream Suppliers
12.3 Acute Migraine Drugs Clients Analysis
12.4 Acute Migraine Drugs Sales Channel and Sales Model Analysis
12.4.1 Acute Migraine Drugs Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Acute Migraine Drugs Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Acute Migraine Drugs Distributors
13 Market Dynamics
13.1 Acute Migraine Drugs Industry Trends
13.2 Acute Migraine Drugs Market Drivers
13.3 Acute Migraine Drugs Market Challenges
13.4 Acute Migraine Drugs Market Restraints
13.5 Porter’s Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
    Table 1. Global Acute Migraine Drugs Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Major Manufacturers of Triptans
    Table 3. Major Manufacturers of NSAIDs
    Table 4. Major Manufacturers of Others
    Table 5. Global Acute Migraine Drugs Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Acute Migraine Drugs Market Size by Region (US$ Million): 2021 VS 2022 VS 2028
    Table 7. Global Acute Migraine Drugs Sales by Region (2017-2022) & (K Unit)
    Table 8. Global Acute Migraine Drugs Sales Forecast by Region (2023-2028) & (K Unit)
    Table 9. Global Acute Migraine Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 10. Global Acute Migraine Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
    Table 11. Global Acute Migraine Drugs Sales by Manufacturer (2017-2022) & (K Unit)
    Table 12. Global Acute Migraine Drugs Sales Share by Manufacturer (2017-2022)
    Table 13. Acute Migraine Drugs Revenue by Manufacturer (2017-2022) & (US$ Million)
    Table 14. Acute Migraine Drugs Revenue Share by Manufacturer (2017-2022)
    Table 15. Key Manufacturers Acute Migraine Drugs Price (2017-2022) & (USD/Unit)
    Table 16. Ranking of Global Top Acute Migraine Drugs Manufacturers by Revenue (US$ Million) in 2021
    Table 17. Global Acute Migraine Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) & (2017-2022)
    Table 18. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Acute Migraine Drugs as of 2021)
    Table 19. Acute Migraine Drugs Manufacturers Manufacturing Base Distribution and Headquarters
    Table 20. Manufacturers Acute Migraine Drugs Product Type
    Table 21. Date of International Manufacturers Enter into Acute Migraine Drugs Market
    Table 22. Manufacturers Mergers & Acquisitions, Expansion Plans
    Table 23. GSK Corporation Information
    Table 24. GSK Description and Business Overview
    Table 25. GSK Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 26. GSK Acute Migraine Drugs Product
    Table 27. GSK Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 28. GSK Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 29. GSK Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 30. GSK Recent Development
    Table 31. Teva Corporation Information
    Table 32. Teva Description and Business Overview
    Table 33. Teva Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 34. Teva Acute Migraine Drugs Product
    Table 35. Teva Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 36. Teva Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 37. Teva Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 38. Teva Recent Development
    Table 39. Pfizer Corporation Information
    Table 40. Pfizer Description and Business Overview
    Table 41. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 42. Pfizer Acute Migraine Drugs Product
    Table 43. Pfizer Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 44. Pfizer Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 45. Pfizer Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 46. Pfizer Recent Development
    Table 47. Novartis Corporation Information
    Table 48. Novartis Description and Business Overview
    Table 49. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 50. Novartis Acute Migraine Drugs Product
    Table 51. Novartis Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 52. Novartis Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 53. Novartis Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 54. Novartis Recent Development
    Table 55. Sun Pharma Corporation Information
    Table 56. Sun Pharma Description and Business Overview
    Table 57. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 58. Sun Pharma Acute Migraine Drugs Product
    Table 59. Sun Pharma Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 60. Sun Pharma Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 61. Sun Pharma Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 62. Sun Pharma Recent Development
    Table 63. Grunenthal Corporation Information
    Table 64. Grunenthal Description and Business Overview
    Table 65. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 66. Grunenthal Acute Migraine Drugs Product
    Table 67. Grunenthal Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 68. Grunenthal Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 69. Grunenthal Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 70. Endo Pharmaceuticals Corporation Information
    Table 71. Endo Pharmaceuticals Description and Business Overview
    Table 72. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 73. Endo Pharmaceuticals Acute Migraine Drugs Product
    Table 74. Endo Pharmaceuticals Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 75. Endo Pharmaceuticals Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 76. Endo Pharmaceuticals Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 77. Merck Corporation Information
    Table 78. Merck Description and Business Overview
    Table 79. Merck Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 80. Merck Acute Migraine Drugs Product
    Table 81. Merck Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 82. Merck Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 83. Merck Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 84. J & J Corporation Information
    Table 85. J & J Description and Business Overview
    Table 86. J & J Acute Migraine Drugs Sales (K Unit), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 87. J & J Acute Migraine Drugs Product
    Table 88. J & J Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Product in 2021
    Table 89. J & J Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Application in 2021
    Table 90. J & J Acute Migraine Drugs Sales Proportion of Acute Migraine Drugs by Geographic Area in 2021
    Table 91. Global Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
    Table 92. Global Acute Migraine Drugs Sales Forecast by Type (2023-2028) & (K Unit)
    Table 93. Global Acute Migraine Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 94. Global Acute Migraine Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
    Table 95. Global Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
    Table 96. Global Acute Migraine Drugs Sales Forecast by Application (2023-2028) & (K Unit)
    Table 97. Global Acute Migraine Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 98. Global Acute Migraine Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
    Table 99. North America Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
    Table 100. North America Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
    Table 101. North America Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 102. North America Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 103. North America Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
    Table 104. North America Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
    Table 105. Asia-Pacific Acute Migraine Drugs Sales by Region (2017-2022) & (K Unit)
    Table 106. Asia-Pacific Acute Migraine Drugs Sales by Region (2023-2028) & (K Unit)
    Table 107. Asia-Pacific Acute Migraine Drugs Revenue by Region (2017-2028) & (US$ Million)
    Table 108. Asia-Pacific Acute Migraine Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 109. Asia-Pacific Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
    Table 110. Asia-Pacific Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
    Table 111. Europe Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
    Table 112. Europe Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
    Table 113. Europe Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 114. Europe Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 115. Europe Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
    Table 116. Europe Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
    Table 117. Latin America Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
    Table 118. Latin America Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
    Table 119. Latin America Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 120. Latin America Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 121. Latin America Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
    Table 122. Latin America Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
    Table 123. Middle East and Africa Acute Migraine Drugs Sales by Country (2017-2022) & (K Unit)
    Table 124. Middle East and Africa Acute Migraine Drugs Sales by Country (2023-2028) & (K Unit)
    Table 125. Middle East and Africa Acute Migraine Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 126. Middle East and Africa Acute Migraine Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 127. Middle East and Africa Acute Migraine Drugs Sales by Type (2017-2022) & (K Unit)
    Table 128. Middle East and Africa Acute Migraine Drugs Sales by Application (2017-2022) & (K Unit)
    Table 129. Acute Migraine Drugs Key Raw Materials, Industry Status and Trend
    Table 130. Acute Migraine Drugs Key Raw Materials and Upstream Suppliers
    Table 131. Acute Migraine Drugs Clients Status and Trend
    Table 132. Acute Migraine Drugs Typical Clients
    Table 133. Acute Migraine Drugs Distributors
    Table 134. Acute Migraine Drugs Market Trends
    Table 135. Acute Migraine Drugs Market Drivers
    Table 136. Acute Migraine Drugs Market Challenges
    Table 137. Acute Migraine Drugs Market Restraints
    Table 138. Research Programs/Design for This Report
    Table 139. Key Data Information from Secondary Sources
    Table 140. Key Data Information from Primary Sources
List of Figures
    Figure 1. Acute Migraine Drugs Product Picture
    Figure 2. Global Acute Migraine Drugs Sales Market Share by Type in 2021 & 2028
    Figure 3. Triptans Product Picture
    Figure 4. NSAIDs Product Picture
    Figure 5. Others Product Picture
    Figure 6. Global Acute Migraine Drugs Sales Market Share by Application in 2021 & 2028
    Figure 7. Hospital Pharmacies Examples
    Figure 8. Drug Stores Examples
    Figure 9. Acute Migraine Drugs Report Years Considered
    Figure 10. Global Acute Migraine Drugs Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Acute Migraine Drugs Market Size 2017-2028 (US$ Million)
    Figure 12. Global Acute Migraine Drugs Sales 2017-2028 (K Unit)
    Figure 13. Global Acute Migraine Drugs Market Size Market Share by Region: 2022 Versus 2028
    Figure 14. Global Acute Migraine Drugs Sales Market Share Forecast by Region (2017-2028)
    Figure 15. Global Acute Migraine Drugs Revenue Market Share by Region (2017-2028)
    Figure 16. Global Acute Migraine Drugs Sales Share by Manufacturer in 2021
    Figure 17. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
    Figure 18. Global Acute Migraine Drugs Sales Market Share Forecast by Type (2017-2028)
    Figure 19. Global Acute Migraine Drugs Revenue Market Share Forecast by Type (2017-2028)
    Figure 20. Acute Migraine Drugs Average Selling Price (ASP) by Type (2017-2022) & (USD/Unit)
    Figure 21. Global Acute Migraine Drugs Sales Market Share Forecast by Application (2017-2028)
    Figure 22. Global Acute Migraine Drugs Revenue Market Share Forecast by Application (2017-2028)
    Figure 23. Acute Migraine Drugs Average Selling Price (ASP) by Application (2017-2022) & (USD/Unit)
    Figure 24. North America Acute Migraine Drugs Revenue 2017-2028 (US$ Million)
    Figure 25. North America Acute Migraine Drugs Sales Market Share by Type (2017-2022)
    Figure 26. North America Acute Migraine Drugs Sales Market Share by Application (2017-2022)
    Figure 27. Asia-Pacific Acute Migraine Drugs Revenue 2017-2028 (US$ Million)
    Figure 28. Asia-Pacific Acute Migraine Drugs Sales Market Share by Region (2017-2028)
    Figure 29. Asia-Pacific Acute Migraine Drugs Revenue Market Share by Region (2017-2028)
    Figure 30. Asia-Pacific Acute Migraine Drugs Sales Market Share by Type (2017-2022)
    Figure 31. Asia-Pacific Acute Migraine Drugs Sales Market Share by Application (2017-2022)
    Figure 32. Europe Acute Migraine Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 33. Europe Acute Migraine Drugs Sales Market Share by Country (2017-2028)
    Figure 34. Europe Acute Migraine Drugs Revenue Market Share by Country (2017-2028)
    Figure 35. Europe Acute Migraine Drugs Sales Market Share by Type (2017-2022)
    Figure 36. Europe Acute Migraine Drugs Sales Market Share by Application (2017-2022)
    Figure 37. Latin America Acute Migraine Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 38. Latin America Acute Migraine Drugs Sales Market Share by Country (2017-2028)
    Figure 39. Latin America Acute Migraine Drugs Revenue Market Share by Country (2017-2022)
    Figure 40. Latin America Acute Migraine Drugs Sales Market Share by Type (2017-2022)
    Figure 41. Latin America Acute Migraine Drugs Sales Market Share by Application (2017-2022)
    Figure 42. Middle East and Africa Acute Migraine Drugs Revenue Growth Rate 2017-2028 (US$ Million)
    Figure 43. Middle East and Africa Acute Migraine Drugs Sales Market Share by Country (2017-2028)
    Figure 44. Middle East and Africa Acute Migraine Drugs Revenue Market Share by Country (2017-2028)
    Figure 45. Middle East and Africa Acute Migraine Drugs Sales Market Share by Type (2017-2022)
    Figure 46. Middle East and Africa Acute Migraine Drugs Sales Market Share by Application (2017-2022)
    Figure 47. Acute Migraine Drugs Supply Chain (Upstream and Downstream Market)
    Figure 48. Global Production Market Share of Acute Migraine Drugs Raw Materials by Region in 2021
    Figure 49. Acute Migraine Drugs Distribution Channels
    Figure 50. Global Acute Migraine Drugs Percentage 2017-2028: Indirect Sales VS Direct Sales
    Figure 51. Global Acute Migraine Drugs Percentage 2017-2028: Online Sales VS Offline Sales
    Figure 52. Bottom-up and Top-down Approaches for This Report
    Figure 53. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS